Alternative Medicine - - The Big Pic­ture -

Fib­rino­gen

car­di­ol­ogy ap­proach does not cre­ate ad­verse ef­fects and may be sup­port­ive for pa­tients with DD.

Meta­bolic car­di­ol­ogy may be an­other treat­ment op­tion to sup­port DD, along with use of tar­geted nu­traceu­ti­cal ther­a­pies in­clud­ing CoQ10, D-ri­bose, L-car­ni­tine, and mag­ne­sium to help for­tify in­suf­fi­cient ATP lev­els in heart tis­sue. Al­though in­flam­ma­tory car­diomy­opa­thy may be a cause of DD, in­flam­ma­tory CAD is a more com­mon man­i­fes­ta­tion of in­flam­ma­tion in the heart. Clin­i­cally, we find the five biomark­ers listed pre­vi­ously use­ful for help­ing clin­i­cians as­sess car­dio­vas­cu­lar risk in healthy and dis­eased pop­u­la­tions. In ad­di­tion, in com­par­i­son to stan­dard lipid pan­els, these biomark­ers can also pro­vide ad­di­tional in­for­ma­tion to guide clin­i­cians with tar­geted treat­ments to re­duce the in­flam­ma­tory bur­den in the body as well as the heart.

Ide­ally, lev­els should be be­tween 180 and 350 mg/dL. One of the best life­style in­ter­ven­tions for low­er­ing fib­rino­gen is to stop smok­ing. Weight loss and ex­er­cise seem to have only a mod­est ef­fect. Omega-3s and nat­tok­i­nase may lower fib­rino­gen as well.

Newspapers in English

Newspapers from USA

© PressReader. All rights reserved.